Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

70.48 +0.10 (+0.14%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers continue to be a major topic as we dive into the latest news investors need to know about on Friday! 
Via InvestorPlace
Amazon, L3Harris Technologies And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
US Market Set To End Week With Whimper As Amazon Drags Nasdaq Futures Lower; Apple, Pinterest, Oil Giants, Inflation Readings In Focus
U.S. index futures are uniformly lower on Friday, as tech stocks continue to drag the overall market. 
Via Benzinga
Edwards Lifesciences Shares Slide As Q2 Results Miss Expectations, Lowers FY22 Sales Outlook
Via Benzinga
Why Pinterest Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
Gainers Zovio Inc (NASDAQ: ZVO) rose 39.5% to $0.2449 in pre-market trading after gaining 7% on Thursday. 
Via Benzinga
Edwards Lifesciences: Q3 Earnings Insights
Edwards Lifesciences (NYSE:EW) reported its Q3 earnings results on Thursday, October 27, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Edwards Slashes 2022 Profit Outlook, Citing Hospital, Dollar Challenges
Edwards Lifesciences slashed its 2022 profit outlook on Thursday, noting hospital and dollar challenges. But EW stock remained muted. 
Via Investor's Business Daily
Edwards Lifesciences's Earnings: A Preview
Edwards Lifesciences (NYSE:EW) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that Edwards... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
Upgrades 
Via Benzinga
Microsoft To $325? Plus This Analyst Sees BlackRock Dropping By 15%
Morgan Stanley lowered the price target on Microsoft Corporation (NASDAQ: MSFT) from $354 to $325. Microsoft shares fell 0.3% to $233.50 in pre-market trading. 
Via Benzinga
Where Edwards Lifesciences Stands With Analysts
Over the past 3 months, 10 analysts have published their opinion on Edwards Lifesciences (NYSE:EW) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand
Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary – The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the... 
Via FinancialNewsMedia
Topics Death Economy
Exposures Death Economy
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
What 8 Analyst Ratings Have To Say About Edwards Lifesciences
Within the last quarter, Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
HC Wainwright Cuts Price Target On This Stock By 50%? Also This Analyst Slashes PT On Cisco
Barclays cut the price target on Cisco Systems, Inc. (NASDAQ: CSCO) from $56 to $46. Barclays analyst Tim Long downgraded the stock from Overweight to Equal-Weight. Cisco shares rose 0.1% to $41.61 in... 
Via Benzinga
Weekend Stock Spotlight: Netflix, Meta, NVIDIA, Disney And The Battle For The Stable Coin Market
Benzinga reviews this weekend's top stories covered by leading media outlets, here are the articles investors need to read. 
Via Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
Via Benzinga
FDA Approves Edwards Lifesciences' PASCAL Precision Transcatheter Valve Repair System For Most Frequent Cardiovascular Disorder
Via Benzinga
Agilent Puts Together Commanding Beat That Ignores Messy Medtech Dynamics
Agilent managed to stave off challenges due to Covid and exchange rates for a big beat. 
Via Investor's Business Daily
Edwards Lifesciences Whale Trades Spotted
Someone with a lot of money to spend has taken a bullish stance on Edwards Lifesciences (NYSE:EW). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Analyzing Edwards Lifesciences's Short Interest
Edwards Lifesciences's (NYSE:EW) short percent of float has risen 6.93% since its last report. The company recently reported that it has 6.66 million shares sold short, which is 1... 
Via Benzinga
Here's How Much $100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 8.15% on an annualized basis producing an average annual return of 19.8%. Currently, Edwards Lifesciences has a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
  
Via Benzinga
Roku, Intel And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! It's time to start off Friday with a breakdown of the biggest pre-market stock movers traders need to know about! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
Recap: Edwards Lifesciences Q2 Earnings
Edwards Lifesciences (NYSE:EW) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Edwards Lifesciences Wipes Out Regular-Session Gains On 2022 Guidance Cut
Edwards Lifesciences now expects sales to grow just 10% on an underlying basis. Exchange rates and hospital staffing are challenging growth. 
Via Investor's Business Daily
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback